TTRX Turn Therapeutics Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ 10-K/10-Q Aug 12, 2026
$10.28
· of 52w range
· above low
· to high
$2.5752w low
$16.4552w high
Market Cap (MRQ)
$306M
P/E
-85.7
EPS
$-0.12
your badges
52W Range
$3–$16
Analyst Rating
BUY
Price Target
$25
P/E
-85.7
ROE
-141.7%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
TTRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.28
Market Cap (MRQ)
$306M
P/E
-85.7
EPS
$-0.12
ROE
-141.7%
Debt/Equity (MRQ)
8.8
52W Range
$3–$16
TTRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.122024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | TTRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -85.7 | · | · | · | |
| P/B (MRQ) | 445.8 | · | 3.0 | Overvalued | |
| Price / Cash Flow | -118.1 | · | · | · | |
| Price / Tangible Book (MRQ) | -1365.0 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | TTRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -45.0% | · | -24.7% | Weak | |
| ROE | -141.7% | · | -28.4% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | TTRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 8.8 | · | · | · | |
| Current Ratio (MRQ) | 1.2 | · | 17.2 | Low liquidity | |
| Quick Ratio | 0.7 | · | 4.7 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 8.8 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-4.2%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jun 25, 2026 | $-0.06 | $-0.03 | -135.3% |
| March 31, 2026 | $-0.03 | $-0.03 | -2.0% | |
| Dec. 31, 2025 | $0.01 | $-0.04 | 124.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $265.6K | $246.0K | |
| SG&A Expense | $6M | $2M | |
| Operating Expenses | $6M | $2M | |
| Operating Income | $-6M | $-2M | |
| Interest Income | $29.6K | $28.7K | |
| Other Non-op | $176.5K | · | |
| Net Income | $-3M | $-2M | |
| EPS (Basic) | $-0.12 | $-0.07 | |
| EPS (Diluted) | $-0.12 | $-0.07 | |
| Shares (Basic) | 27,716,045 | 26,643,432 | |
| Shares (Diluted) | 27,716,045 | 26,643,432 | |
| EBITDA | $-6M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $4M | $498.3K | |
| Prepaid Expense | $120.3K | $225.3K | |
| Current Assets | $5M | $1M | |
| Intangibles | $922.2K | $821.9K | |
| Total Assets | $12M | $2M | |
| Current Liabilities | $6M | $707.9K | |
| Capital Leases | $34.1K | $80.4K | |
| Total Liabilities | $7M | $2M | |
| Common Stock | $2.9K | $2.7K | |
| Retained Earnings | $-22M | $-19M | |
| Stockholders' Equity | $5M | $-177.4K | |
| Liabilities + Equity | $12M | $2M | |
| Shares Outstanding | 29,445,183 | 26,845,690 |
Cash Flow
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $52.7K | $47.5K | |
| Stock-based Comp | $419.2K | $352.8K | |
| Amort. of Intangibles | $53.0K | $47.0K | |
| Operating Cash Flow | $-3M | $-1M | |
| Investing Cash Flow | $-153.0K | $-99.5K | |
| Stock Issued | $7M | $1M | |
| Net Stock Activity | $7M | · | |
| Financing Cash Flow | $7M | $1M |
Profitability
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | -45.0% | · | |
| ROE | -141.7% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 0.9 | · | |
| Quick Ratio | 0.7 | · |
Per Share
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Book Value / Share | $0.16 | · | |
| Cash Flow / Share | $-0.09 | · | |
| Cash / Share | $0.14 | · | |
| EPS (TTM) | $-0.12 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-3M | · | |
| Market Cap | $116M | · | |
| P/E | -32.8 | · | |
| P/B | 24.8 | · | |
| P / Tangible Book | 30.8 | · | |
| P / Cash Flow | -45.3 | · | |
| Earnings Yield | -3.0% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $475.1K | $109.4K | $34.9K | $158.7K | $62.7K | $9.3K | $9.8K | $153.3K | |
| SG&A Expense | $1M | $1M | $2M | $2M | $1M | $375.7K | $319.2K | $519.7K | |
| Operating Expenses | $2M | $1M | $2M | $2M | $1M | $385.0K | $329.0K | $673.0K | |
| Operating Income | $-2M | $-1M | $-2M | $-2M | $-1M | $-385.0K | $-329.0K | $-673.0K | |
| Interest Income | · | $49.7K | $14.2K | $5.1K | · | $5.2K | $5.8K | $6.5K | |
| Other Non-op | · | $5.6K | $0 | $4.3K | $121.0K | $51.3K | · | · | |
| Net Income | $-6M | $-971.0K | $279.1K | $-2M | $-1M | $-328.5K | $-323.1K | $-666.4K | |
| EPS (Basic) | $-0.20 | $-0.03 | $0.01 | $-0.07 | $-0.05 | $-0.01 | $-0.02 | $-0.03 | |
| EPS (Diluted) | $-0.20 | $-0.03 | $0.01 | $-0.07 | $-0.05 | $-0.01 | $-0.02 | $-0.03 | |
| Shares (Basic) | 29,788,040 | 29,476,002 | · | 27,975,207 | 27,494,483 | 26,956,217 | · | 26,645,835 | |
| Shares (Diluted) | 29,788,040 | 29,476,002 | · | 27,975,207 | 27,494,483 | 26,956,217 | · | 26,645,835 | |
| EBITDA | $-2M | $-1M | · | $-2M | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $11M | $4M | $513.7K | · | · | $498.3K | · | |
| Prepaid Expense | $139.7K | $235.2K | $120.3K | $188.6K | · | · | $225.3K | · | |
| Current Assets | $10M | $11M | $5M | $3M | · | · | $1M | · | |
| Intangibles | $911.2K | $919.9K | $922.2K | $904.9K | · | · | $821.9K | · | |
| Total Assets | $17M | $19M | $12M | $4M | · | · | $2M | · | |
| Current Liabilities | $9M | $5M | $6M | $2M | · | · | $707.9K | · | |
| Capital Leases | $8.7K | $21.5K | $34.1K | $46.3K | · | · | $80.4K | · | |
| Total Liabilities | $16M | $13M | $7M | $4M | · | · | $2M | · | |
| Long-term Debt | $7M | $7M | · | · | · | · | · | · | |
| Total Debt | $6M | $6M | · | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $2.9K | $2.8K | · | · | $2.7K | · | |
| Retained Earnings | $-29M | $-23M | $-22M | $-23M | · | · | $-19M | · | |
| Stockholders' Equity | $686.9K | $6M | $5M | $504.0K | · | · | $-177.4K | · | |
| Liabilities + Equity | $17M | $19M | $12M | $4M | · | · | $2M | · | |
| Shares Outstanding | 29,788,040 | 29,788,040 | 29,445,183 | 28,022,826 | · | · | 26,845,690 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $419.2K | $280.8K | $256.4K | $39.1K | $47.2K | $76.6K | $37.8K | · | |
| Operating Cash Flow | $-923.4K | $-2M | $-1M | $-588.6K | $-500.0K | $-298.1K | $-430.5K | · | |
| Investing Cash Flow | $-5.8K | $-12.2K | $-31.4K | $-89.8K | · | · | $-7.8K | · | |
| Stock Issued | · | · | $3M | $594.6K | $2M | $998.1K | $522.2K | · | |
| Financing Cash Flow | $1 | $8M | $3M | $594.6K | $2M | $998.1K | $522.2K | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -69.0% | -10.4% | · | -88.6% | · | · | · | · | |
| ROE | -1703.3% | -31.7% | · | -755.6% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.2 | · | 1.4 | · | · | · | · | |
| Quick Ratio | 1.1 | 2.1 | · | 0.2 | · | · | · | · | |
| Debt / Equity | 8.8 | 1.0 | · | · | · | · | · | · | |
| LT Debt / Equity | 8.8 | 1.0 | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.02 | $0.21 | · | $0.02 | · | · | · | · | |
| Cash Flow / Share | · | $-0.06 | · | · | · | · | · | · | |
| Cash / Share | $0.33 | $0.37 | · | $0.02 | · | · | · | · | |
| EPS (TTM) | $-0.29 | $-0.14 | · | $-0.15 | $-0.11 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-8M | $-4M | · | $-4M | $-3M | · | · | · | |
| Market Cap | $217M | $95M | · | · | · | · | · | · | |
| Enterprise Value | $214M | $90M | · | · | · | · | · | · | |
| P/E | -25.2 | -22.9 | · | · | · | · | · | · | |
| P/B | 316.6 | 15.6 | · | · | · | · | · | · | |
| P / Tangible Book | · | 18.3 | · | · | · | · | · | · | |
| P / Cash Flow | · | -58.4 | · | · | · | · | · | · | |
| Earnings Yield | -4.0% | -4.4% | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Income | $-3M | $-2M |
| Diluted EPS | $-0.12 | $-0.07 |
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Current Ratio | 0.9 | · |
| Quick Ratio | 0.7 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 30 filers · $11.5M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
30
Value held
$11.5M
New positions
11
Exited positions
2
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (+8 vs prior Q) | 2 (-2 vs prior Q) | 4 (+1 vs prior Q) | 2 (0 vs prior Q) | +694K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| SteelPeak Wealth, LLC | $3,615,848 | 251,275 | 31.34% | Shares |
| IEQ CAPITAL, LLC | $1,659,991 | 227,396 | 14.39% | Shares |
| DDFG, Inc | $1,602,748 | 111,379 | 13.89% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $542,397 | 74,301 | 4.70% | Shares |
| Wellington Shields & Co., LLC | $479,844 | 65,732 | 4.16% | Shares |
| Aaron Wealth Advisors LLC | $468,596 | 32,564 | 4.06% | Shares |
| MILLENNIUM MANAGEMENT LLC | $442,022 | 60,551 | 3.83% | Shares |
| BlackRock, Inc. | $281,715 | 38,591 | 2.44% | Shares |
| Bridgewater Advisors Inc. | $241,562 | 27,326 | 2.09% | Shares |
| Tamar Securities, LLC | $219,000 | 30,000 | 1.90% | Shares |
| McCarthy Asset Management, Inc. | $216,109 | 15,018 | 1.87% | Shares |
| ROYAL BANK OF CANADA | $206,000 | 28,250 | 1.79% | Shares |
| CITADEL ADVISORS LLC | $188,880 | 25,874 | 1.64% | Shares |
| BROWN BROTHERS HARRIMAN & CO | $172,922 | 23,688 | 1.50% | Shares |
| Cannon Financial Strategists, Inc. | $143,900 | 10,000 | 1.25% | Shares |
| HighTower Advisors, LLC | $143,693 | 19,684 | 1.25% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $125,136 | 17,142 | 1.08% | Shares |
| Jefferies Financial Group Inc. | $118,990 | 16,300 | 1.03% | Shares |
| VANGUARD GROUP INC | $118,814 | 30,156 | 1.03% | Shares |
| Composition Wealth, LLC | $116,800 | 16,000 | 1.01% | Shares |
| BANK OF AMERICA CORP /DE/ | $103,105 | 14,124 | 0.89% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $91,104 | 12,480 | 0.79% | Shares |
| MORGAN STANLEY | $82,833 | 11,347 | 0.72% | Shares |
| LPL Financial LLC | $75,190 | 10,300 | 0.65% | Shares |
| TD Waterhouse Canada Inc. | $40,375 | 3,059 | 0.35% | Shares |
| UBS Group AG | $16,520 | 2,263 | 0.14% | Shares |
| Blue Trust, Inc. | $16,146 | 1,122 | 0.14% | Shares |
| WELLS FARGO & COMPANY/MN | $7,300 | 1,000 | 0.06% | Shares |
| Pflug Koory, LLC | $1,241 | 170 | 0.01% | Shares |
| Caitong International Asset Management Co., Ltd | $226 | 31 | 0.00% | Shares |
Company insiders 7 insiders · 2 officers · 5 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Zuraiz Chaudhary | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | April 1, 2026 A | 12,500 | 4 | 0 | $24,874 |
| Neilesh Shailesh Ghodadra | Chief Medical Officer | Oct. 8, 2025 A | 10,000 | 0 | 0 | $0 |
| Martin William Dewhurst | Director | June 4, 2026 A | 21,882 | 0 | 0 | $0 |
| Kent Edward Kester | Director | June 4, 2026 A | 10,000 | 0 | 0 | $0 |
| Andrew Gengos | Director | June 4, 2026 A | 10,000 | 0 | 0 | $0 |
| Arthur F Golden | Director | June 4, 2026 A | 360,602 | 2 | 0 | $92,873 |
| Abraham Chesed | · | Oct. 23, 2025 P | 1,447,268 | 1 | 0 | $65,716 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
TTRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$25.00
+143.2%
3 33.3%
Strong Buy
4 44.4%
Buy
1 11.1%
Hold
1 11.1%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-10-23Mean target $25.00 +143.2%
← Below all targets
Current price $10.28
Low$24.00
Mean$25.00
High$26.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026